Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer.

Journal of cancer research and clinical oncology - 1 Oct 2020

Zeng Yu, Li Nanhong, Liu Wang, Zeng Mingqing, Cheng Junfen, Huang Jian

Abstract excerpt

BACKGROUND: Despite great advances in its early diagnosis and treatment, lung cancer is still an intractable disease and the second leading cause of cancer-related deaths and morbidity in the world. The family of Polo-like kinases (PLKs) consists of five serine/threonine kinases, which have been reported to participate in various human diseases. However, the expression and prognostic value of each PLK in human...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Cycle Proteins

Share to Polo-Like Kinase 1

Share to Protein Serine-Threonine Kinases

Share to Proto-Oncogene Proteins

Share to Transcriptome

Share to Tumor Suppressor Proteins

Source

Identifiers

PMID: 32627077
DOI: 10.1007/s00432-020-03288-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer.PMID 32627077Read ↗

Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancerSemantic proximity Read ↗

Analysis of the effect of NEKs on the prognosis of patients with Non-small-cell lung carcinoma based on bioinformaticsSemantic proximity Read ↗

Analysis of the effect of NEKs on the prognosis of patients with non-small-cell lung carcinoma based on bioinformatics.Semantic proximity Read ↗

Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancerSemantic proximity Read ↗

PLEK2 activates the PI3K/AKT signaling pathway to drive lung adenocarcinoma progression by upregulating SPC25Semantic proximity Read ↗

PLEK2 and SCN7A: novel biomarkers of non-small cell lung cancerSemantic proximity Read ↗

PLEK2 and SCN7A: novel biomarkers of non-small cell lung cancerSemantic proximity Read ↗

PLEK2 promotes lung adenocarcinoma progression via activating the PI3K/AKT signaling pathway through SPC25 Running title: PLEK2 promotes LUAD via SPC25/PI3K/AKT axisSemantic proximity Read ↗

Expression and clinical significance of PRKDC in lung cancer based on bioinformatics analysisSemantic proximity Read ↗

PLEK2 Gene Upregulation Might Independently Predict Shorter Progression-Free Survival in Lung AdenocarcinomaSemantic proximity Read ↗

Comprehensive analysis of PLKs expression and prognosis in breast cancer.Semantic proximity Read ↗

Identification and validation of key genes with prognostic value in non‐small‐cell lung cancer via integrated bioinformatics analysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.